BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16715704)

  • 1. [Prognostic significance of tumor cell ploidy in advanced ovarian carcinoma].
    Novik VI; Gevorkian VA; Maksimov SIa
    Vopr Onkol; 2006; 52(1):54-8. PubMed ID: 16715704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic variables, operative characteristics, and DNA ploidy in predicting outcome in ovarian epithelial carcinoma.
    Rice LW; Mark SD; Berkowitz RS; Goff BA; Lage JM
    Obstet Gynecol; 1995 Sep; 86(3):379-85. PubMed ID: 7651646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma.
    Kramer BA; Gao X; Davis M; Hall M; Holzbeierlein J; Tawfik O
    J Am Coll Surg; 2005 Oct; 201(4):565-70. PubMed ID: 16183495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic significance of DNA ploidy in disseminated malignant skin melanoma and the effectiveness of interleukin-2 (IL-2) treatment].
    Novik AV; Novik BI; Moiseenko VM
    Vopr Onkol; 2007; 53(2):164-9. PubMed ID: 17663169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 as a prognostic factor for stage III serous adenocarcinoma of the ovary.
    Daponte A; Guidozi F; Tiltman AJ; Marineanu A; Taylor L
    Anticancer Res; 1999; 19(3B):2387-9. PubMed ID: 10472362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction and utilization of the prognostic model of serous ovarian adenocarcinoma].
    Yang R; Feng J; Fang XZ; Bai F; Cheng YX; Liu C; Zhu W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):459-63. PubMed ID: 17083811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of DNA ploidy patterns of colorectal adenocarcinoma.
    Lin JK; Chang SC; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2003; 50(54):1927-32. PubMed ID: 14696434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of DNA content and S-phase fraction in epithelial ovarian carcinomas analyzed by image cytometry.
    Reles AE; Gee C; Schellschmidt I; Schmider A; Unger M; Friedmann W; Lichtenegger W; Press MF
    Gynecol Oncol; 1998 Oct; 71(1):3-13. PubMed ID: 9784312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic and predictive value of syntactic structure analysis in serous carcinoma of the ovary.
    Palmer JE; Sant Cassia LJ; Irwin CJ; Morris AG; Janssen EA; Baak JP; Rollason TP
    Int J Gynecol Pathol; 2008 Apr; 27(2):191-8. PubMed ID: 18317224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
    Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC
    Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivariate analysis of DNA ploidy, steroid hormone receptors, and CA 125 as prognostic factors in ovarian carcinoma: a prospective study.
    Eissa S; Khalifa A; Laban M; Mohamed MK; Elian A
    Nutrition; 1995; 11(5 Suppl):622-6. PubMed ID: 8748237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [DNA ploidy in epithelial ovarian cancer--an independent prognostic factor].
    Tropé CG; Abeler V; Baekelandt M; Kaern J
    Tidsskr Nor Laegeforen; 2000 Jan; 120(1):43-9. PubMed ID: 10815478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of DNA ploidy analysis in endometrial adenocarcinoma.
    Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
    Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of prognostic significance of ploidy and S-phase measurements in advanced ovarian cancer.
    Coley HM; Sargent JM; Titley J; Taylor CG
    Anticancer Res; 1999; 19(3A):2111-6. PubMed ID: 10470157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulosa cell tumor of the ovary: retrospective analysis of 45 cases.
    Uygun K; Aydiner A; Saip P; Basaran M; Tas F; Kocak Z; Dincer M; Topuz E
    Am J Clin Oncol; 2003 Oct; 26(5):517-21. PubMed ID: 14528083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
    J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
    Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
    Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.